Healthcare and Life Science
Optibrium demonstrates superior molecular docking method for small molecules and macrocycles
Surflex-Dock structure-based design method outperforms other molecular docking methods for predicting non-cognate ligand pose of macrocyclic compounds Results published Open Access in Journal of Computer-Aided Molecular Design ...
Cambridge Independent Business Awards 2024
We are thrilled to announce that Costello Medical won two prestigious awards at the inaugural Cambridge Independent Business Awards 2024! Congratulations to all the winners and finalists from the other categories and a big thank you to the Cambridge Independent for putting on such a won...
Costello Medical Consulting Annual Impact Report
Our 2023/24 Annual Impact Report is available to read.
Award highlights from Costello Medical Consulting
Award winning commitment.
Costello Medical Consulting gains B Corp Certification
Leading the way in reinventing business by pursuing purpose as well as profit.
Axol Bioscience acquires Phenocell to advance human disease models
Acquisition expands Axol’s iPSC-derived cell models and service offering to include ophthalmology and dermatology CAMBRIDGE / EDINBURGH, UK, and GRASSE, FRANCE, 21 October 2024: Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug ...
The impact of AI on the event production industry: jobs created and lost
Every event we’ve worked on in the last 12 months has in some way mentioned AI (except Munich Beer Festival and Top Clown UK). ...
eg technology launch Technology Readiness Level (TRL) assessment
Comprised of both a self-assessment diagnostic tool, through which innovators can assess the Technology Readiness Level of each integral element of their development, and a Framework, detailing the stages of product development maturity, our TRL assessment is a pract...
ESMO 2024 review: Improving patient survival through innovations in oncology
European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, bringing together the global oncology community to share the latest data, innovations, and advancements in cancer care. ...
Psoriasis patient source of business for major IL-17 agents
Source of business for leading IL-17 agents in psoriasis varies significantly by brand. While the majority of Cosentyx patients are previously treated with a TNF inhibitor, a sizable portion of Taltz patients have tried another IL-17 agent before starting Taltz. This finding suggests a ...